What’s up, Doc?

Fed­eral Reg­u­la­tions Pose New Chal­lenges to Nat­u­ral Prod­uct Ac­cess

Alternative Medicine - - The Big Picture - BY JOHN WEEKS

con­stel­la­tion of re­cent ac­tiv­ity from fed­eral agen­cies raises new ques­tions about po­ten­tial re­stric­tions on con­sumer and prac­ti­tioner ac­cess to nat­u­ral prod­ucts. The first three ini­tia­tives be­low are from the Food and Drug Ad­min­is­tra­tion (FDA), his­tor­i­cally viewed as an ad­ver­sary by many users of dietary sup­ple­ments and other nat­u­ral health prod­ucts. The fourth is from the Drug En­force­ment Ad­min­is­tra­tion (DEA).

Home­o­pathic Teething Agents as well as mor­tal­i­ties. Was there an er­rant man­u­fac­turer sell­ing prod­uct as a low-po­tency home­o­pathic that could make it harm­ful? Was a mix of some agent like bel­ladonna im­prop­erly po­ten­ti­ated by a man­u­fac­turer? Or is the cam­paign a gra­tu­itous as­sault on the in­dus­try, as some be­lieve? At the time of writ­ing this col­umn, rep­re­sen­ta­tives of the Na­tional Cen­ter for Homeopa­thy shared that they an­tic­i­pate fil­ing a Free­dom of In­for­ma­tion Act re­quest to learn more about what pro­voked the FDA ac­tion.

New Dietary In­gre­di­ents His or­ga­ni­za­tion es­ti­mates that the FDA’s guid­ance will pro­duce be­tween $377 mil­lion and $5 bil­lion per year in ad­di­tional costs to man­u­fac­tur­ers, and thus, to con­sumers. Nat­u­ral prod­ucts con­sul­tant Michael Levin of Health Busi­ness Strate­gies has been or­ga­niz­ing prac­ti­tion­ers and their or­ga­ni­za­tions to be heard on the topic. Is­raelsen’s or­ga­ni­za­tion has been the most out­spo­ken on the topic among the nat­u­ral prod­ucts in­dus­try or­ga­ni­za­tions.

Ac­cess to Nat­u­ral Agents from Com­pound­ing Phar­ma­cies

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.